null - FindTrial

N/A - TAP

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-004167-68-ES

Enrollment

104

Registered

2012-01-19

Start date

2012-04-27

Completion date

Unknown

Last updated

2012-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

104 patients will be randomized to each of the two groups to apply TAP or femoral block, after which they were placed in lateral decubitus position and proceed to the performance of spinal anesthesia. The group will perform TAP TAP block with 30 ml of levobupivacaine 0.125% and the femoral group perform femoral block, levobuivacaína injecting 10 ml of 0.25%. Both blocks will be guided by ultrasound.

Interventions

Trade Name: levobupivacaine Product Name: CHIROCANE Product Code: LEVOBUPIVACAINA Pharmaceutical Form: Solution for injection/concentrate for solution for infusion CAS Number: 27262-48-2 Current Spons

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: - Sing of consent - More than 65 years old - ASA clasification (I-III) for anestesic risk - Hip fracture with parcial arthroplasty surgical treatment Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) no F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 104

Exclusion criteria

Exclusion criteria: exclusion criteria: - Anestesic allergy - Mental illness - Periferic neuropathy - Intradural anesthetic contraindication

Design outcomes

Primary

Measure	Time frame
Main Objective: To evaluate effectiveness of postoperative analgesic in TAP block versus femoral block in hip fracture;Secondary Objective: - To analyze the necessity of postoperative analgesic - To value the effectiveness of block between both group - To compare their stay in URPA - To value the satisfaction in the patient;Primary end point(s): After the surgery and the patient extubated, will move into the recovery room post-anesthesia (PACU).;Timepoint(s) of evaluation of this end point: In PACU the patient will pass the EVA survey to analyze the degree of pain.	—

Measure

Time frame

Main Objective: To evaluate effectiveness of postoperative analgesic in TAP block versus femoral block in hip fracture;Secondary Objective: - To analyze the necessity of postoperative analgesic - To value the effectiveness of block between both group - To compare their stay in URPA - To value the satisfaction in the patient;Primary end point(s): After the surgery and the patient extubated, will move into the recovery room post-anesthesia (PACU).;Timepoint(s) of evaluation of this end point: In PACU the patient will pass the EVA survey to analyze the degree of pain.

—

Secondary

Measure	Time frame
Secondary end point(s): At 24 hours reflects the degree of patient satisfaction.;Timepoint(s) of evaluation of this end point: Satisfaction Survey	—

Countries

Spain

Contacts

Public ContactFRANCISCO MANUEL LUQUE MARTINEZ

MARIA TERESA PARRAS MALDONADO

franciscom.luque.exts@juntadeandalucia.es+34953008077

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026